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A B S T R A C T
Background: Post-infarction ventricular septal rupture (VSR) is a rare but lethal mechanical complication
of an acute myocardial infarction (AMI). Survival to 1 month without intervention is 6%. Given high
surgical mortality, transcatheter closure has emerged as a potential strategy in selected cases. Indian
data on percutaneous device closure of post AMI-VSR is scarce hence we report our single-centre
experience with ASD occluder device (Amplatzer and lifetech) for closure of post-AMI VSR.
Methods and results: In this single-centre, retrospective, cohort study, patients who underwent
transcatheter closure of post-MI VSR between 2005 and 2015 at KIMS Hospital were included. Primary
outcome was mortality rate at 30 days. Seven patients were included in the study (mean age,
58.29  9.8 years). 5 patients had anterior wall myocardial infarction (AWMI) & 2 had inferior wall
myocardial infarction (IWMI). None of the patients received thrombolytic therapy. Device was successfully
placed in 5 patients (71.4%) with minimal residual shunt in 2 patients (40%). Out of 7 cases 2 patients survived
(29% survival rate) and are doing well on follow up at 1 and 5 years respectively. Cardiogenic shock, IWMI and
serpigenious form of VSR were associated with poor outcomes. Delayed revascularization (PCI) was
associated with better outcomes.
Conclusion: Percutaneous closure is a potential technique in a selected group of patients. The presence of
cardiogenic shock, IWMI and serpigeneous form of VSR constitutes important risk factors for mortality.
Device implantation is in general successful with few procedure-related complications and should be
applied on a case-by-case basis.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents lists available at ScienceDirect
Indian Heart Journal
jo u rn al h om epag e: ww w.els evier .c o m/lo cat e/ ih j1. Introduction
Post-infarction ventricular septum rupture (VSR) is a potential-
ly lethal mechanical complication of an acute myocardial
infarction (AMI). Due to the implantation of early revascularisation
strategies, the incidence of post-infarction VSR has decreased from
1–2% to 0.25–0.31%.1 However, when it does occur is commonly
associated with extensive comorbidities, and results in poor
cardiac output, multiorgan failure, and death. When conservative
treatment is applied, mortality rates are as high as 87–100% within
2 months of diagnosis.2,3 Expert opinion and professional guide-
lines suggest that immediate closure, often combined with
(multiple) coronary artery bypass grafting should be considered
to reduce the duration of poor systemic perfusion that results from
left-to-right shunting, pulmonary over circulation, and systemic
hypoperfusion that may eventuate in refractory multiple organ* Corresponding author.
E-mail address: kumarpre@hotmail.com (R.K. Premchand).
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creativecommons.org/licenses/by-nc-nd/4.0/).failure and death.4 Despite this awareness, there is a tendency for
surgeons to wait several weeks before operating to allow tissue
healing and more complete rupture remodelling, contributing to
high inter-stage mortality and positive selection of more favour-
able cases. Due to the high mortality rate, less invasive alternative
treatments, such as the use of percutaneous occluders, have been
investigated. The advent of the Amplatzer family of ventricular
septal defect (VSD) closure devices offers a potentially attractive
alternative to surgical repair. A few case reports in Indian literature
has been published but as such no case series reported.5,6 Though
data is available in form of case reports and series world-wide.7,8
We hereby report our case series on percutaneous closure of post
MI VSR using the ASD occluder device (Amplatzer and lifetech)
who presented between 2005 and 2015.
2. Method
Device closure for VSR after acute MI has been attempted at our
centre since December 2005. We analysed the case records
available from the ﬁrst case in December 2005 until June 2015. Datalosure of post-myocardial infarction ventricular septal rupture – A
.1016/j.ihj.2016.10.004
 India. This is an open access article under the CC BY-NC-ND license (http://
Table 1
Demographic data.
Demographic Data
Total cases 7
Male:female 2:5
Mean age (years) 58.29  9.8
Diabetic 4
Hypertensive 5
Anterior MI 5
Inferior MI 2
Mean duration from MI onset to presentation (hours) 22.14 h
Mean duration from MI to procedure (days) 5.29  2.73
Cardiogenic shock 4 (57.1%)
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pre-procedural clinical condition, echocardiographic features,
procedural characteristics, procedural complications, in-hospital
and 30 days mortality and long term follow up result. Cardiogenic
shock was deﬁned according to the Should We Emergently
Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK)
trial.9 Coronary artery disease was deﬁned as >70% stenosis in 1 of
the 3 major epicardial coronary arteries.
As per hospital data records from 2005 to 2015, 25 patients
were admitted with post MI–VSR. Out of these 7 cases (non
consecutive) underwent percutaneous device closure and 11 cases
underwent surgery.
3. Clinical parameters of the cases studied
In this single-centre, retrospective, cohort study where 7 non
consecutive cases (4 females and 3 males) of post-MI VSR were
included. The demographic data is summarised in Table 1. The
mean age of the population was 58.29  9.8 years
(57.67  10.2 years in males and 58.75  11.08 years in females).
Majority of the patients in our series had an anterior wall MI (5 of
7 cases; 71.43%) and the remaining 2 had an inferior wall MI. All the
patients did not receive thrombolytic therapy or any other form of
intervention for the AMI. All cases had late presentation (>12 h to
>38 h from the onset of chest pain). The mean duration from onset of
pain to presentation at our centre was 22.14 h. Presence of ventricular
septal rupture was identiﬁed clinically with the presence of a pan-
systolic murmur along the lower left sternal border and conﬁrmed by
performing an echocardiogram (Fig. 1a). All patients were managed
by placing an intra aortic balloon pump (IABP) for afterload reduction
and consequent reduction of the left to right shunt. 4 patients
presented with cardiogenic shock (57.14%) and required inotropic
support with dopamine and noradrenaline. Of the two patients with
IWMI one developed complete heart block and needed temporary
pacemaker insertion (TPI) and one needed Continuous renal
replacement therapy (CRRT) for acute kidney injury. Mean duration
from acute MI to procedure for attempted device closure was
5.29  2.73 days.
4. Procedure
The technique of percutaneous closure of a VSR is based upon
the well proven and widely used percutaneous technique for
closing a congenital ventricular septal defect. Transesophageal
echocardiography (TEE) with colour Doppler is used to determine
the size and anatomy of the VSR (Fig. 1b). Left Ventricular
angiogram was done to determine the exact location of the VSR.
Cannulation of the right femoral artery and right internal jugular
vein is performed using the Seldinger technique. A guidewire (03500Fig. 1. (a) PSAX and (b) transesophageal echocardiog
Please cite this article in press as: Premchand RK, et al. Percutaneous c
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the aorta into the left ventricle and is advanced through the VSR
into the right ventricle and pulmonary artery. A second snaring
wire is introduced through the vein to connect to the guidewire in
the pulmonary artery. By retracting the snared wires, the
guidewire now forms an arteriovenous (AV) loop (Fig. 2a). The
delivery sheath is advanced from the venous side loop over the
guidewire through the VSR into the left ventricle. Correct
positioning of the delivery sheath is conﬁrmed in ﬂuoroscopy/
TEE. The guidewire is then retracted leaving the delivery sheath in
position. After echocardiographic conﬁrmation an ASD occluder
device (liftech in 3 cases and amplatzer in 4 cases) was deployed
across VSR using the delivery sheath. The distal disc is opened, the
device is retracted, so that it will be secured against the septal
tissue at the side of the left ventricle. The second (proximal) disc is
opened on the right ventricular side by further retracting the
delivery sheath (Fig. 2b). Correct positioning of the device and
closure is conﬁrmed by echocardiography and/or ﬂuoroscopy. If
placement is satisfactory, the occluder is released. Post procedure
Left ventricular angiography & Echocardiography was done to
conﬁrm the position and to rule out presence of any residual
shunt. In all the cases, we made use of the femoral-jugular mode of
access and created an AV loop. The veno-venous loop though
described in literature was not used in this study. VSR Closure in
all these cases was attempted using an ASD occluder device
(3 Lifetech and 4 Amplatzer), the size depending upon the size of
the VSR.
5. Results
All patients included in this study were cases with VSR in whom
previous attempts at closure had not been done (primary closure).
Of the 7 cases in this study the device was successfully placed in
5 patients (71.4%). Post procedural result was good with a minimal
residual shunt in 2 patients (40%). Out of 7 cases 3 patients wereram showing the VSR in a patient with AWMI.
losure of post-myocardial infarction ventricular septal rupture – A
.1016/j.ihj.2016.10.004
Fig. 2. (a) Creating an AV loop and (b) device placed across VSR.
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to death within 30 days. In patients with in-hospital mortality,
mean duration from procedure to mortality was 3.46  2.12 days.
Of the 4 patients who had cardiogenic shock on presentation, 3 had in
hospital mortality (75%). There were 5 cases with anterior wall
MI + VSR and 2 cases with inferior wall MI + VSR. In patients with
anterior wall VSR, 40% (2 cases) survived >30 days while those with
inferior wall VSR (2 cases) died in hospital post procedure.
One patient with inferior wall VSR had a large serpiginous VSR
with associated hypotension, ARF and complete heart block for
which a TPI was done. Due to the serpiginous nature of the VSR
device placement was not successful. The other patient with IWMI
also had a failure of device placement due to difﬁcult location of
the VSR. Both these patients developed severe haemodynamic
compromise and needed intervention within 3 days of VSR.
Surgical closure was considered but due to extreme surgical risk,
interventional device closure was attempted but failed and both
succumbed on table.
In this series, all patients with anterior wall MI (5 cases) had a
successful device placement with minimal residual shunt in two
patients. Out of 5 cases 3 patients were discharged successfully but
only 2 patients survived till 30 days. One case died during IABP
removal (which was wrongly oversized) due to external iliac artery
tear leading to haemodynamic compromise and other case
developed haemothorax and water shed zone infarct due to which
he had respiratory arrest, could not be extubated and expired after
a prolonged course. Patient who died after discharge was
readmitted with worsening dyspnoea had a VSR expansion post
device closure and developed worsening of the left to right shunt,
leading to refractory heart failure and death.
The nature of the underlying coronary artery disease in patients
in this study was extremely variable with 3 patients having single
vessel disease (SVD), 3 patients having two vessel (DVD) and
1 patient having triple vessel disease (TVD).
The 2 patients who survived also had a stormy post device
closure course in the ICCU with one patient developing acalculous
cholecystitis and severe sepsis with multiorgan dysfuction. With
aggressive medical therapy the patient recovered and was
discharged on day 7 after device closure. Both the patients who
survived had a good post discharge recovery and are on regular
follow up. The coronary lesions (SVD in one case and 2VD in
another) in these 2 patients were stented 4 weeks after discharge
with good results. Both cases are doing well on 1 and 5 years
follow-up respectively.
As per hospital data out of 25 patients (2005–2015) admitted
with post MI VSR 11 patients underwent surgical closure alongPlease cite this article in press as: Premchand RK, et al. Percutaneous c
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11 cases died in hospital (36.3%) while 2 died in 1 year follow up
(18.18%).
6. Discussion
Ventricular septum rupture (VSR) complicating AMI is a
relatively rare event associated with high mortality with an
incidence of 0.2% in current era. In patients with cardiogenic shock,
VSR is the underlying cause in 3.9%, and mortality can be as high as
87.3%, as was seen in the SHOCK trial registry.9 Without surgical
repair of postinfarction VSR reported mortality is 90% within
2 months.10
In two prospective registries, the mortality rates were as high as
81–100% for patients with VSR and shock.2,3 As a result of the high
mortality and suboptimal surgical results with a postoperative
residual shunt found in up to 20% of the treated patients, the
technique of percutaneous VSR device closure has been devel-
oped.2,11–13 Currently, data is limited for post-infarction VSR
interventional closure in Indian literature.
In this series, the success rate of device placement for VSR
closure was 71.4% which is comparable to the global reportable
success rate of 85%.10 The largest single-centre experience with
device closure of primary VSR reported was in 29 patients,13 which
found a survival rate at 30 days of 35%. In this series the 30 day
survival rate was comparable at 29%. Although one of the largest
multicenter study on percutaneous device closure of post MI VSR
(both primary and post surgery residual VSR included) reported
survival of 58% at the time of discharge which reduced to 51.5% on
1 year of follow up.14 But even in this study mean duration from MI
to percutaneous closure of VSR was 13 days while in our study
patients were intervened in acute settings (<7 days). A comparison
with the currently available world data on primary VSR device
closure is given in Table 2. The mortality rate in VSR with
cardiogenic shock has been reported at 88%13 while in our study
we had 75% mortality. In patients with RV dysfunction and inferior
wall VSRs, mortality had been reported to be close to 100% and
surgery is reported to be futile in these patients.15 Even in this
series it was found that patients with inferior wall VSRs and RV
dysfunction had a mortality of 100%. Even those patients who have
a successful device closure of the VSR often succumb to antecedent
causes. The post VSR closure course in the ICCU is often stormy and
requires careful monitoring to detect complications early and
manage them appropriately. This study highlights that coronary
lesions should be addressed on later date for better results and
primary focus should be on correction of mechanical complication.losure of post-myocardial infarction ventricular septal rupture – A
.1016/j.ihj.2016.10.004
Table 2
Comparison of results of world experience with our series1.
Total
patients
Acute (n) Subacute/chronic (n) Success
rate
30 days survival
(acute)
30 days
survival (s/c)
Residual shunt
(small)
Residual shunt
(mod/sev)
Chessa 2002 12 3 9 11/12 0/3 8/9 0 0
Szkutnik 2003 7 0 7 5/7 – 4/5 3 1
Goldstein 2003 4 0 4 3/4 – 3/3 2 2
Haizer 2004 18 5 13 16/18 2/5 9/13 8 2
Demikow 2005 11 3 8 10/11 0/2 8/8 4 0
Martinez 2007 5 3 2 5/5 2/3 2/2 3 1
Bialkowski 2007 19 1 18 14/19 0/1 9/13 9 3
Marinakis 2007 8 6 2 7/8 0/6 1/2 0 0
Ahmed 2008 5 2 3 4/5 0/1 3/3 3 1
Maltais 2009 12 12 0 11/12 7/11 – 10 1
Thiele 2009 29 29 0 25/29 10/29 – 6 4
Total no 130 64 66 111/130 21/61 47/58 48/111 15/111
Total (%) 85 34 81 43 14
Premchand RK 2015 7 7 0 5/7 2/7 – 2/5 0
Total (%) 72 29 – 33 0
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closure is highlighted at the end of study. The limited number of
patients in this series precluded any meaningful multivariable
analysis to identify independent predictors of mortality hence
future studies with larger sample size are recommended.
7. Conclusion
Post-AMI VSR remains a lethal complication of acute coronary
syndromes. The detrimental interplay of cardiogenic shock,
intracardiac shunting, and increased pulmonary circulation
frequently results in severe multiorgan failure and leads to high
risk of mortality. Percutaneous closure is a potential technique in a
selected group of patients. The presence of cardiogenic shock,
IWMI and early revascularization (PCI) in the acute phase after VSR
diagnosis are important risk factors of mortality. Device implanta-
tion is in general successful with few procedure-related complica-
tions and should be applied on a case-by-case basis.
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